These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22275170)

  • 1. Defining urinary urgency: patient descriptions of "gotta go".
    Coyne KS; Harding G; Jumadilova Z; Weiss JP
    Neurourol Urodyn; 2012 Apr; 31(4):455-9. PubMed ID: 22275170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptom severity and patient perceptions in overactive bladder: how are they related?
    Homma Y; Gotoh M
    BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the urinary sensation scale (USS).
    Coyne KS; Margolis MK; Hsieh R; Vats V; Chapple CR
    Neurourol Urodyn; 2011 Mar; 30(3):360-5. PubMed ID: 21254195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urgency assessment in the evaluation of overactive bladder (OAB).
    Starkman JS; Dmochowski RR
    Neurourol Urodyn; 2008; 27(1):13-21. PubMed ID: 17671973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two types of urgency.
    Blaivas JG; Panagopoulos G; Weiss JP; Somaroo C
    Neurourol Urodyn; 2009; 28(3):188-90. PubMed ID: 19306331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse.
    Foster RT; Barber MD; Parasio MF; Walters MD; Weidner AC; Amundsen CL
    Am J Obstet Gynecol; 2007 Jul; 197(1):82.e1-4. PubMed ID: 17618768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a 3-item OAB awareness tool.
    Coyne KS; Margolis MK; Bavendam T; Roberts R; Elinoff V
    Int J Clin Pract; 2011 Feb; 65(2):219-24. PubMed ID: 21235701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining overactive bladder as hypersensitivity.
    Yamaguchi O; Honda K; Nomiya M; Shishido K; Kakizaki H; Tanaka H; Yamanishi T; Homma Y; Takeda M; Araki I; Obara K; Nishizawa O; Igawa Y; Goto M; Yokoyama O; Seki N; Takei M; Yoshida M
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):904-7. PubMed ID: 17663416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Chapple C; Herschorn S; Abrams P; Sun F; Brodsky M; Guan Z
    Eur Urol; 2009 Sep; 56(3):534-41. PubMed ID: 19070418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of bladder diary with urinary perception to assess overactive bladder symptoms in community-dwelling women.
    Honjo H; Kawauchi A; Ukimura O; Nakao M; Kitakoji H; Miki T
    Neurourol Urodyn; 2009; 28(8):982-5. PubMed ID: 19267392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
    Rovner ES; Rackley R; Nitti VW; Wang JT; Guan Z;
    Urology; 2008 Sep; 72(3):488-93. PubMed ID: 18639327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
    Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
    J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Urgency tip": a portable patient-activated device for objective measurement of urinary urgency.
    Kobayashi H; Araki I; Tsuchida T; Zakoji H; Mikami Y; Takeda M; Kiyohiro N
    Urology; 2007 Mar; 69(3):570-1. PubMed ID: 17382170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.